A technical answer to what makes genetic testing private: who holds the raw files, what the consent terms permit, how re-identifiable the data is, and how to store and analyze a genome yourself.
A technical guide to choosing and using a biomarker testing service: what analytes are worth measuring, what the analytical error looks like, how to store and version the results, and where a clinician has to be involved.
A working guide to running DESeq2 on bulk RNA-seq counts. Covers the count matrix, dispersion, shrinkage and the sanity checks that catch most mistakes.
A worked walkthrough of what real DNA results look like: array text files, VCF lines field by field, coverage and callability checks, annotation with VEP, and what a 'positive' result does and does not mean.
A practical protocol for estimating functional age from physical performance tests, blood chemistry algorithms, and DNA methylation clocks, with the reliability problems that make most single-timepoint results uninterpretable.
A breakdown of the genomic testing market by category — clinical labs, direct-to-consumer arrays, research-grade sequencing providers, and tumor profiling — with the file formats, coverage depths, and failure modes that decide whether the data is useful to you.
What direct-access lab testing is, how self-ordered blood work is priced, and how to store and interpret your own results as structured data rather than PDFs.
A step-by-step pipeline for small RNA sequencing data, from adapter chemistry and UMI handling through hierarchical annotation, isomiR-level quantification, and differential expression, with the biofluid-specific failure modes that break naive runs.
A working guide to reading, normalizing, filtering, annotating, and querying a Variant Call Format file from whole-genome sequencing, including how to get a slice of it into a spreadsheet without breaking it.
A breakdown of WES pricing: research-grade versus CLIA-clinical, what drives the per-sample cost, how trios are billed, and why the sequencing is the cheap part of the project.
Consumer 30x WGS runs $300-600, clinical CLIA-reported WGS runs roughly $1,000-3,000 out of pocket, and the difference is depth, deliverables, and interpretation rather than sequencing chemistry. Here is how to read a price and verify what you received.
A breakdown of consumer, research-core, and clinical whole genome sequencing prices, what each tier gets you in files and coverage, and where the hidden costs sit.
An essay prompted by Alan Kay's 2011 talk on why the Internet and living systems scale while most software does not, with his numbers checked against real sources, and what the argument implies for a personal molecular data system built from a genome, a blood panel, and a glucose trace.
A working guide to diagnosing and handling batch effects in bulk RNA-seq, from design and TMM normalization through limma, ComBat-seq, and RUV, with the checks that tell you whether the correction helped.
An essay prompted by Carolyn Bertozzi's lecture on bioorthogonal chemistry: what the reactions are, the second-order rate constants that decide what can be imaged in a living animal, and why the glycome is still a missing data layer in most molecular profiles.
How to use R and Bioconductor as the annotation, statistics, and integration layer for a personal molecular dataset: VCFs, RNA-seq counts, proteomics, and continuous glucose data, with the parts you should not do in R.